Spirodiketopiperazine-based CCR5 antagonist: Discovery of an antiretroviral drug candidate

被引：9

作者：

Nishizawa, Rena ^{[1
]}

Nishiyama, Toshihiko ^{[1
]}

Hisaichi, Katsuya ^{[1
]}

Minamoto, Chiaki ^{[1
]}

Matsunaga, Naoki ^{[1
]}

Takaoka, Yoshikazu ^{[1
]}

Nakai, Hisao ^{[1
]}

Jenkinson, Stephen ^{[3
]}

Kazmierski, Wieslaw M. ^{[3
]}

Tada, Hideaki ^{[2
]}

Sagawa, Kenji ^{[2
]}

Shibayama, Shiro ^{[2
]}

Fukushima, Daikichi ^{[2
]}

Maeda, Kenji ^{[4
,5
]}

Mitsuya, Hiroaki ^{[4
,5
]}

机构：

[1] Ono Pharmaceut Co Ltd, Med Chem Res Lab, Osaka 6188585, Japan

[2] Ono Pharmaceut Co Ltd, Exploratory Res Lab, Ibaraki 300424, Japan

[3] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC 27709 USA

[4] Kumamoto Univ, Sch Med, Dept Internal Med 2, Kumamoto 8600811, Japan

[5] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 04期

关键词：

CCR5; Chemokine; Anti-HIV; CHEMOKINE RECEPTOR; HIV-1; INFECTION; VIRAL ENTRY; CORECEPTOR; COFACTOR; POTENT;

D O I：

10.1016/j.bmcl.2010.12.109

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Following the discovery that hydroxylated derivative 3 (Fig. 1) was one of the oxidative metabolites of the original lead 1, it was found that hydroxylated compound 4 possesses higher in vitro anti-HIV potency than the corresponding non-hydroxylated compound 2. Structural hybridation of 4 with the orally available analog 5 resulted in another orally-available spirodiketopiperazine CCR5 antagonist 6a that possesses more favorable pharmaceutical profile for use as a drug candidate. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：1141 / 1145

页数：5

共 50 条

[41] Association of the CCR5Δ32 mutation with improved response to antiretroviral therapy
Valdez, H
Purvis, SF
Lederman, MM
Fillingame, M
Zimmerman, PA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08): : 734 - 734
[42] Discovery of CCR5 antagonists containing the aminoguanidine group.
Kesicki, EA
Odingo, JO
Oliver, AR
Orme, MW
Schweickart, VL
Epp, A
Gray, PW
Fowler, KW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U19 - U19
[43] CCR5 antagonists have different conformational requirements for the transition to the most thermodynamically stable CCR5 receptor: antagonist complex.
Swinney, DC
Beavis, P
Kondru, RK
Dioszegi, ME
Gee, P
Zhang, J
Sankuratri, S
Mirzadegan, T
FASEB JOURNAL, 2006, 20 (05): : A918 - A919
[44] The discovery of tropane-derived CCR5 receptor antagonists
Armour, DR
de Groot, MJ
Price, DA
Stammen, BLC
Wood, A
Perros, M
Burt, C
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (04) : 305 - 308
[45] Testing a CCR5 drug? Avoid mosquito bites
Crabb, C
AIDS, 2006, 20 (08) : N3 - N4
[46] The CC Chemokine Receptor 5 (CCR5) antagonist Maraviroc inhibits drug-choice in Sprague Dawley rats
Mason, Briana
Seaman, Robert, Jr.
Collins, Gregory
FASEB JOURNAL, 2021, 35
[47] CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice -: Clinical implications for CCR5 inhibition as antiretroviral therapy -: Reply
Moreno, C
Devière, J
Louis, H
HEPATOLOGY, 2006, 43 (04) : 879 - 880
[48] Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist
Zheng, Changsheng
Cao, Ganfeng
Xia, Michael
Feng, Hao
Glenn, Joseph
Anand, Rajan
Zhang, Ke
Huang, Taisheng
Wang, Anlai
Kong, Ling
Li, Mei
Galya, Laurine
Hughes, Robert O.
Devraj, Rajesh
Morton, Phillip A.
Rogier, D. Joseph
Covington, Maryanne
Baribaud, Fred
Shin, Niu
Scherle, Peggy
Diamond, Sharon
Yeleswaram, Swamy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
Xue, Chu-Biao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1442 - 1446
[49] Determination of nifeviroc, a novel CCR5 antagonist: Application to a pharmacokinetic study
Wu, Wei
Xie, Dong
Cheng, Zeneng
Liu, Zhi
Ran, Liling
Gu, Zhenkun
Yu, Peng
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 56 (03) : 637 - 640
[50] Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1-Infected, Treatment-Experienced, CCR5 Antagonist-Naive Subjects
Lalezari, Jacob
Gathe, Joseph
Brinson, Cynthia
Thompson, Melanie
Cohen, Calvin
Dejesus, Edwin
Galindez, Jorge
Ernst, Jerome A.
Martin, David E.
Palleja, Sandra M.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (02) : 118 - 125

← 1 2 3 4 5 →